FKBP1A Human

FK506 Binding Protein 1A Human Recombinant
Cat. No.
BT20143
Source
Escherichia Coli.
Synonyms
FKBP12, PPIase, Peptidyl-prolyl cis-trans isomerase, Rotamase, FKBP-12, FKBP1, PKC12, PKCI2, FKBP12C, FKBP1A, PPIase FKBP1A, FK506-binding protein 1A, 12 kDa FKBP, FKBP-1A.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 99.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

FKPB1A Human Recombinant fused to N-terminal His-Tag produced in E.Coli is a single, non-glycosylated polypeptide chain purified through a Ni2+-affinity chromatography followed by gel filtration.

Product Specs

Introduction
FKBP1A, a 12kDa protein, was first identified in immune cells due to its ability to bind FK506, an immunosuppressant, and mediate its effects within cells. This protein is also known to play a role in mediating the effects of rapamycin, another immunosuppressive agent. FKBP1A belongs to the immunophilin family, a group of proteins known for their high affinity for immunosuppressant drugs and their peptidyl-prolyl cis-trans isomerase (PPIase) activity. PPIase activity is involved in the proper folding of proteins containing proline. When not bound to immunosuppressive ligands, FKBP1A participates in regulating intracellular calcium levels by associating with three types of Ca2+ release channel complexes: those found in skeletal muscle (ryanodine receptors), those found in cardiac muscle (ryanodine receptors), and inositol 1,4,5-triphosphate receptors. Additionally, FKBP1A interacts with the TGF-b type I receptor, inhibiting the TGF-b signaling pathway. FKBP12 plays a role in modulating ryanodine receptor isoform-1 (ryr-1), a key component of the calcium release channel found in the sarcoplasmic reticulum of skeletal muscle. FKBP1A enhances protein folding and catalyzes the conversion of proline imidic peptide bonds from the cis to trans isomer in oligopeptides.
Description
Recombinant human FKBP1A, with an N-terminal His-Tag, was produced in E. coli. This protein is a single, non-glycosylated polypeptide chain purified using Ni2+-affinity chromatography, followed by gel filtration.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The FKBP1A protein solution is formulated in a buffer containing 50mM Hepes (pH 8.0), 150mM NaCl, 0.5mM EDTA, and 1mM sodium azide.
Stability
For short-term storage (up to 4 weeks), keep the vial refrigerated at 4°C. For long-term storage, freeze the protein at -20°C. Adding a carrier protein like HSA or BSA (0.1%) is recommended for long-term storage. Avoid repeatedly freezing and thawing the protein.
Purity
The purity of this protein is greater than 99.0% as determined by SDS-PAGE analysis.
Synonyms
FKBP12, PPIase, Peptidyl-prolyl cis-trans isomerase, Rotamase, FKBP-12, FKBP1, PKC12, PKCI2, FKBP12C, FKBP1A, PPIase FKBP1A, FK506-binding protein 1A, 12 kDa FKBP, FKBP-1A.
Source
Escherichia Coli.
Amino Acid Sequence
The amino acid sequence of recombinant His-tagged FKBP12 is reported as following:
MAHHHHHHVMGVQVETISPGDGRTFPKRGQTCVV
HYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGW
EEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHAT
LVFDVELLKLE.

Product Science Overview

Introduction

FK506 Binding Protein 1A (FKBP1A), also known as FKBP12, is a member of the FK506-binding protein family. These proteins are known for their role in immunosuppression and protein folding. FKBP1A is particularly notable for its ability to bind the immunosuppressant molecule tacrolimus (originally designated FK506), which is used in treating patients after organ transplant and those with autoimmune disorders .

Structure and Function

FKBP1A is a peptidyl-prolyl cis-trans isomerase (PPIase), which means it catalyzes the isomerization of peptide bonds at proline residues in proteins. This activity is crucial for protein folding and function. The protein has a high affinity for FK506 and rapamycin, another immunosuppressant .

When FKBP1A binds to FK506, the complex inhibits the phosphatase activity of calcineurin. This inhibition blocks the signal transduction pathway in T-lymphocytes, preventing the activation of these immune cells and thereby exerting an immunosuppressive effect .

Biological Role

Beyond its role in immunosuppression, FKBP1A is involved in various cellular processes. It acts as a chaperone, assisting in the proper folding of proteins containing proline residues. FKBP1A also interacts with several other proteins and receptors, influencing pathways related to cell growth, differentiation, and apoptosis .

Clinical Significance

The ability of FKBP1A to bind FK506 and rapamycin has significant clinical implications. Tacrolimus is widely used to prevent organ rejection in transplant patients. It has been found to reduce episodes of organ rejection more effectively than ciclosporin, another immunosuppressant that binds to cyclophilin . Both the FKBP-tacrolimus complex and the cyclosporin-cyclophilin complex inhibit calcineurin, but tacrolimus has a higher potency.

Research Applications

FKBP1A is also a valuable tool in biological research. It does not normally form dimers but will dimerize in the presence of FK1012, a derivative of FK506. This property makes it useful for chemically induced dimerization applications, where it can be used to manipulate protein localization, signaling pathways, and protein activation .

Evolutionary Perspective

FKBP1A shares homology with FKBP proteins found in other eukaryotes, ranging from yeast to humans. This evolutionary conservation suggests that FKBPs have fundamental roles in cellular physiology. Comparative studies have shown that FKBP proteins in mammals and Drosophila melanogaster (fruit flies) have similar functions, although there are differences in their mechanisms of action .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.